Atria Wealth Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$772K 1987
2024
Q4
$772K Buy
+1,000
New +$828K 0.01% 1035

Other funds holding LLY

Atria Wealth Solutions's LLY Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Eli Lilly (LLY) stake by 66% in Q2 2025, selling an estimated $19.6M and leaving 12,987 shares worth $10.1M. The position accounts for 0.23% of the portfolio, ranked #99.

Atria Wealth Solutions first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $39.3M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Atria Wealth Solutions held 12,987 shares of Eli Lilly worth $10.1M as of Q2 2025.
  • Atria Wealth Solutions sold 25,286 Eli Lilly shares in Q2 2025, an estimated $19.6M.
  • Eli Lilly made up 0.23% of Atria Wealth Solutions's portfolio in Q2 2025, its #99 holding.
  • Atria Wealth Solutions first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Eli Lilly position peaked at $39.3M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.